Sign In
Buy NDAQ
$77.65
-3.96 (-4.85%)
At Close: Jun 25, 2026
Eastside Distilling Announces $0.4 Million Registered Direct Offering, Priced at a Premium to Market Under Nasdaq Rules
03:30pm, Thursday, 05'th Sep 2024
PORTLAND, Ore., Sept. 5, 2024 /PRNewswire/ -- Eastside Distilling, Inc. (Nasdaq: EAST) ("Eastside"), a consumer-focused beverage company that builds craft inspired experiential brands and high-quality
Nasdaq Stock Rallies 42.5% in a Year: More Room for Upside?
12:16pm, Thursday, 05'th Sep 2024
NDAQ stock gains from impressive organic growth, strategic buyouts to capitalize on growing market opportunities and effective capital deployment.
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:30am, Thursday, 05'th Sep 2024
REDWOOD CITY, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that on September 3, 2024, the Compensation Committee of Adverum's Board of Direct
RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
07:00am, Thursday, 05'th Sep 2024
TEL AVIV, Israel and RALEIGH, N.C. , Sept. 5, 2024 /PRNewswire/ -- RedHill Biopharma Ltd.
S&P 500, Nasdaq Fall For 2nd Straight Session Amid Nvidia Decline: Fear & Greed Index In 'Neutral' Zone
02:55am, Thursday, 05'th Sep 2024
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index in the “Neutral” zone on Wednesday.
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:49pm, Wednesday, 04'th Sep 2024
SAN FRANCISCO, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Wednesday, 04'th Sep 2024
WALTHAM, Mass. and DUBLIN, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapie
Nasdaq Executives to Present at Upcoming Investor Conferences
04:15pm, Wednesday, 04'th Sep 2024
NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conferences in September with webcasts available at Nasdaq's Investor Relations website: ir.nasda
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:10pm, Wednesday, 04'th Sep 2024
BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Wednesday, 04'th Sep 2024
CHARLESTOWN, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and
Nasdaq Reports August 2024 Volumes
04:05pm, Wednesday, 04'th Sep 2024
NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for August 2024 on its Investor Relations website. A data sheet showing this information can be found
ASLAN Pharmaceuticals Limited; Conn's, Inc.; 2U, Inc.; International Media Acquisition Corp.; Presto Automation, Inc.; and VBI Vaccines, Inc.; from The Nasdaq Stock Market ASLAN Pharmaceuticals Limi
60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
08:00am, Wednesday, 04'th Sep 2024
60 Degrees Pharmaceuticals raises $4M through private placement for working capital, commercialization, and R&D, with H.C. Wainwright as placement agent.
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:00am, Wednesday, 04'th Sep 2024
RESEARCH TRIANGLE PARK, N.C., Sept. 04, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted
Laser Photonics Regains Compliance With Nasdaq Listing Requirements
05:33pm, Tuesday, 03'rd Sep 2024
ORLANDO, Fla.--(BUSINESS WIRE)--Laser Photonics Corporation (LPC) (NASDAQ: LASE), a leading global industrial developer of laser systems for cleaning and other material processing applications, announ
